Literature DB >> 2495302

Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency.

E H Birkenmeier1, M T Davisson, W G Beamer, R E Ganschow, C A Vogler, B Gwynn, K A Lyford, L M Maltais, C J Wawrzyniak.   

Abstract

We have characterized a new mutant mouse that has virtually no beta-glucuronidase activity. This biochemical defect causes a murine lysosomal storage disease that has many interesting similarities to human mucopolysaccharidosis type VII (MPS VII; Sly syndrome; beta-glucuronidase deficiency). Genetic analysis showed that the mutation is inherited as an autosomal recessive that maps to the beta-glucuronidase gene complex, [Gus], on the distal end of chromosome 5. Although there is a greater than 200-fold reduction in the beta-glucuronidase mRNA concentration in mutant tissues, Southern blot analysis failed to detect any abnormalities in the structural gene, Gus-sb, or in 17 kb of 5' flanking and 4 kb of 3' flanking sequences. Surprisingly, a sensitive S1 nuclease assay indicated that the relative level of kidney gusmps mRNA responded normally to androgen induction by increasing approximately 11-fold. Analysis of this mutant mouse may offer valuable information on the pathogenesis of human MPS VII and provide a useful system in which to study bone marrow transplantation and gene transfer methods of therapy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495302      PMCID: PMC303816          DOI: 10.1172/JCI114010

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  The effect of mutation on the intracellular location of beta-glucuronidase.

Authors:  K PAIGEN
Journal:  Exp Cell Res       Date:  1961-11       Impact factor: 3.905

3.  Mucopolysaccharidosis. VII. Beta-glucuronidase deficiency.

Authors:  J Gehler; M Cantz; M Tolksdorf; J Spranger; E Gilbert; H Drube
Journal:  Humangenetik       Date:  1974-07-15

4.  Beta glucuronidase deficiency: report of clinical, radiologic, and biochemical features of a new mucopolysaccharidosis.

Authors:  W S Sly; B A Quinton; W H McAlister; D L Rimoin
Journal:  J Pediatr       Date:  1973-02       Impact factor: 4.406

5.  Beta-glucuronidase deficiency mucopolysaccharidosis.

Authors:  W S Sly; F E Brot; J Glaser; P D Stahl; B A Quinton; D L Rimoin; W H McAlister
Journal:  Birth Defects Orig Artic Ser       Date:  1974

6.  Glucuronidase phenotypes of inbred mouse strains.

Authors:  R Ganschow; K Paigen
Journal:  Genetics       Date:  1968-07       Impact factor: 4.562

7.  Mitochondrial malate dehydrogenase and malic enzyme: Mendelian inherited electrophoretic variants in the mouse.

Authors:  T B Shows; V M Chapman; F H Ruddle
Journal:  Biochem Genet       Date:  1970-12       Impact factor: 1.890

8.  Inherited histocompatibility changes in progeny of irradiated and unirradiated inbred mice.

Authors:  D W Bailey; H I Kohn
Journal:  Genet Res       Date:  1965-11       Impact factor: 1.588

9.  Beta-glucuronidase deficiency mucopolysaccharidosis: methods for enzymatic diagnosis.

Authors:  J H Glaser; W S Sly
Journal:  J Lab Clin Med       Date:  1973-12

10.  Purification and chemical properities of mouse liver lysosomal (L form) beta-glucuronidase.

Authors:  S Tomino; K Paigen; D R Tulsiani; O Touster
Journal:  J Biol Chem       Date:  1975-11-10       Impact factor: 5.157

View more
  72 in total

Review 1.  Brain-directed gene therapy for lysosomal storage disease: going well beyond the blood- brain barrier.

Authors:  William S Sly; Carole Vogler
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-30       Impact factor: 11.205

Review 2.  Mouse chromosome 5.

Authors:  C A Kozak; D A Stephenson
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

3.  Tissue refractometry using Hilbert phase microscopy.

Authors:  Niyom Lue; Joerg Bewersdorf; Mark D Lessard; Kamran Badizadegan; Ramachandra R Dasari; Michael S Feld; Gabriel Popescu
Journal:  Opt Lett       Date:  2007-12-15       Impact factor: 3.776

Review 4.  Application of Mouse Models to Research in Hearing and Balance.

Authors:  Kevin K Ohlemiller; Sherri M Jones; Kenneth R Johnson
Journal:  J Assoc Res Otolaryngol       Date:  2016-10-17

Review 5.  Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.

Authors:  C Vogler; M S Sands; N Galvin; B Levy; C Thorpe; J Barker; W S Sly
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

6.  The characterization of a murine model of mucopolysaccharidosis II (Hunter syndrome).

Authors:  A R Garcia; J Pan; J C Lamsa; J Muenzer
Journal:  J Inherit Metab Dis       Date:  2007-09-16       Impact factor: 4.982

7.  Phenotype correction in retinal pigment epithelium in murine mucopolysaccharidosis VII by adenovirus-mediated gene transfer.

Authors:  T Li; B L Davidson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

Review 8.  Gene therapy for lysosomal storage diseases (LSDs) in large animal models.

Authors:  Mark Haskins
Journal:  ILAR J       Date:  2009

9.  A single-base-pair deletion in the beta-glucuronidase gene accounts for the phenotype of murine mucopolysaccharidosis type VII.

Authors:  M S Sands; E H Birkenmeier
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

10.  Long circulating enzyme replacement therapy rescues bone pathology in mucopolysaccharidosis VII murine model.

Authors:  Daniel J Rowan; Shunji Tomatsu; Jeffrey H Grubb; Bisong Haupt; Adriana M Montaño; Hirotaka Oikawa; Angela C Sosa; Anping Chen; William S Sly
Journal:  Mol Genet Metab       Date:  2012-07-14       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.